Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Improving and Measuring Osteoporosis Management

In the United States, an estimated 10 million people are living with osteoporosis, also called brittle bone disease. Although osteoporosis is responsible for the majority of hip fractures, and accounts for more than $18 billion in health care expenditures annually, on average only 20% of patients are ever screened or treated for the disease. This monograph, developed by The Joint Commission through an unrestricted educational grant by the National Pharmaceutical Council, contains 10 voluntary measures of care designed for a variety of health care settings. This monograph is intended for a professional audience and contains clinical information and practical tips for implementing an osteoporosis improvement initiative, whether clinical care is given in a hospital, emergency department, rehabilitation facility, home health agency, or doctor's office.

Blog Post

The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes

Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into...
Blog Post

#TBT: Alzheimer’s & Access to Health Information

As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with...
Newsletter Volume

E.V.I.dently February 2014

Message From NPCAs PCORI Funds Head-to-Head Comparisons, Research Must Remain Meaningful, TransparentIn the years since its establishment, the...
Newsletter Volume

E.V.I.dently November 2013

MessageCER Collaborative Is Assessing Evidence and Informing Decision-MakingToday we’re faced with an ever-growing availability of health information...
Press Release

Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council’s Chairman of the Board

WASHINGTON, DC (November 2, 2012)–The National Pharmaceutical Council (NPC) today announced that John Gargiulo, President & CEO, Daiichi Sankyo,...
Press Release

Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research

WASHINGTON, DC (September 11, 2012)—A new set of principles developed by a group of leading researchers could help to ensure more consistency in how...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals

WASHINGTON, DC, July 18, 2012–As health care providers set up accountable care organizations (ACOs) and other value-based care programs,...
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
Commentary and Testimony Page

High Stakes for Setting Research Standards

What is the cost of poorly designed research? In the comparative effectiveness arena, faulty studies could mean that consumers may make important...
Commentary and Testimony Page

Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals

Medications are more than an item on the balance sheet for health care providers. Pharmaceuticals offer a route to manage costs while achieving...
YouTube Videos

Rapid-Learning Health Care Systems, Explained

Dr. Lucy Savitz, director of research and education, Institute for Healthcare Delivery Research, Intermountain Healthcare, explains rapid learning...
YouTube Videos

PCORI Outlines Efforts to Engage Patients

Dr. Rachael Fleurence, Scientist,Patient-Centered Outcomes Research Institute, outlines the many ways heragency is engaging patients and other...
YouTube Videos

Challenges in Communicating Comparative Effectiveness Research

Dr. Robert Dubois, Chief Science Officer, National Pharmaceutical Council (NPC), describes the issue of "asymmetry" in the comparative effectiveness...
YouTube Videos

UPenn's Dr. Caplan on Communicating CER to Patients

Univ. of Pennsylvania Director of the Center for Bioethics Dr. Art Caplan outlines an ethical framework for communicating comparative effectiveness...
Blog Post

The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes

Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into...
Blog Post

#TBT: Alzheimer’s & Access to Health Information

As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with...
Blog Post

AMCP 2013 Nexus: Addressing Critical Pharmacy Issues

Specialty pharmacy, health care reform, clinical breakthroughs and research in managed care are among the featured topics at the AMCP 2013 Nexus, a...
Blog Post

Catch These Upcoming Events and Publications

September was a particularly busy month, featuring a variety of health care conferences, meetings, publications, and ongoing debates about the...

Research

The Myth of Average: Why Individual Patient Differences Matter

Within today’s health care environment, so much of t

Imputing Productivity Gains From Clinical Trials

Researchers developed a new method to capture the impact that medicines may have on reducing the...

Role of Pharmaceuticals in Value-Based Healthcare: A Framework for Success

This research sets out a conceptual framework for considering the role of pharmaceuticals in...
  •  
  • 1 of 42
  • >

Commentary & Testimony